Archive: 03/06/2019

Double success for innovative 'child-friendly' HIV treatment

University of Liverpool's Nanomedicine research has been recognized by The (US) President's Emergency Plan for AIDS Relief and a fundraising campaign to help improve drug therapies for children with HIV has reached its target ...

Jun 3, 2019

0

6

Precision drug combo boosts survival in younger women with advanced breast cancer

Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.

Jun 3, 2019

0

9

Study finds link between Medicaid expansion and equity in cancer care

Racial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to an analysis of over 30,000 health records led by researchers at Yale Cancer Center. ...

Jun 3, 2019

0

1

Mapping brain cell geometries by considering random paths of water molecules

In her doctoral thesis at University of Jyväskylä, M.Sc. Jia Liu has developed and implemented a series of new computational statistical methodologies to deal with diffusion-MRI data. The statistical problem of the thesis ...

Jun 3, 2019

0

4

The Virtual Brain simulates the brain to reveal the origins of disorders

A cognitive irony is that the human brain's very complexity makes it difficult to theorize about its workings, using thought alone. However, computer models can simulate the consequences of theories, identifying problems ...

Jun 3, 2019

0

21

Suggested benefit in PCV chemoradiotherapy for both IDH-mutant WHO-defined molecular subgroups

A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase 1/2 (IDH) mutation status and 1p/19q co-deletion status represented in the high-risk treatment arms of the ...

Jun 3, 2019

Trial sets new standard regimen for women with uterine carcinosarcomas

Results from the phase III NRG Oncology clinical trial GOG 0261 comparing paclitaxel plus carboplatin (PC) to paclitaxel plus ifosfamide (PI) in women with stage I-IV, recurrent carcinosarcoma of the uterus or ovary, indicate ...

Jun 3, 2019

Patients who received PBI without chemotherapy experienced less fatigue, slightly poorer cosmesis

Patient-reported outcome (PRO) data indicates that partial breast irradiation (PBI) is more convenient than whole breast irradiation (WBI) for women with breast cancer who do not receive adjuvant chemotherapy. These participants ...

Jun 3, 2019